http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020147852-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15c71ca08224228efb984614e12df9a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4d6f303f51487297fb3525576fd8fc7 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00 |
filingDate | 2020-01-19^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96a5de7ff75478d49b388a5aeed36c16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbb953c1720113b5a6f5acade58fdaab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b73ba7f4df6aff59ab097b2bfd3b287 |
publicationDate | 2020-07-23^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2020147852-A1 |
titleOfInvention | Crystal forms of antidepressant drug sage-217 and preparation method therefor |
abstract | The present application relates to crystal form 04, crystal form 06, crystal form D-1, and crystal form D-2 of an antidepressant drug SAGE-217 and a preparation method therefor and a pharmaceutical composition containing same. The XRPD of crystal form 04 has characteristic peaks at 2theta values of 11.6±0.2°, 13.5±0.2°, 16.2±0.2°, 16.5±0.2°, and 23.2±0.2°; the XRPD of crystal form 06 has characteristic peaks at 2theta values of 8.7±0.2°, 10.0±0.2°, 13.2±0.2°, 15.0±0.2°, 15.8±0.2°, and 17.3±0.2°; the XRPD of crystal form D-1 has characteristic peaks at 2theta values of 7.2±0.2°, 8.6±0.2°, 13.3±0.2°, 19.6±0.2°, and 23.0±0.2°; and the XRPD of crystal form D-2 has characteristic peaks at 2theta values of 7.3±0.2°, 8.6±0.2°, 13.4±0.2°, 19.7±0.2°, and 23.3±0.2°. The new crystal forms provided by the present application have good stability, and provide more choices for drug development. |
priorityDate | 2019-01-20^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 46 of 46.